Stock Price
1,513.00
Daily Change
11.35 0.76%
Monthly
10.62%
Yearly
26.96%
Q2 Forecast
1,478.96

Aurobindo Pharma reported INR86.46B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Cipla INR 65.41B 9.77B Mar/2026
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Dr.Reddys Laboratories INR 75.46B 11.81B Mar/2026
Hindustan Unilever INR 159.96B 2.01B Mar/2026
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
UPL INR 183.35B 59.74B Mar/2026